Pleased to announce Barts Life Sciences are recruiting for our second digital fellow post for CAP-AI, our pioneering research programme, aiming to place healthcare in East London at the forefront of the AI and technology revolution. More information and how to apply can be found here: http://jobs.bartshealth.nhs.uk/job/v3008688
Barts Life Sciences is delighted to announce that we are recruiting for digital fellows for our next cohort of artificial intelligence and machine learning projects, CAP-AI. Details and how to apply can be found here: https://www.jobs.nhs.uk/xi/vacancy/916408493
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust. The results are published in the New...
Researchers from Barts Cancer Institute (BCI), Queen Mary University of London, have released a web-based tool called SNPnexus COVID (https://www.snp-nexus.org/v4/covid/) to streamline the analysis of host genetic sequencing data and allow for the identification and prioritisation of genetic variants that may impact an individual’s susceptibility to and the severity of COVID-19 infection. Since the emergence of the COVID-19 pandemic, global initiatives to...
This week, Barts Health NHS Trust reached a significant milestone in the fight against Covid-19. Since the pandemic started, the Trust has recruited more than 10,000 participants across 34 different Covid-19 studies, including 15 National Institute for Health Research ‘Urgent Public Health’ studies. This major contribution to the national effort against the virus has been achieved in the midst of...
New research suggests that a higher dietary intake of long chain omega-3 fatty acids in childhood may reduce the risk of developing subsequent asthma, but only in children carrying a common gene variant. The study, led by Queen Mary University of London, is in collaboration with the University of Bristol and University of Southampton, UK, and Karolinska Institutet, Sweden. In...
Researchers at Queen Mary University of London and Barts Health NHS Trust are looking for clinical trial participants who have recently (within 8 days) been in contact with someone who has tested positive for Covid-19. The STORM CHASER study is looking at whether a combination of two investigational antibodies, developed by AstraZeneca, works in the prevention of COVID-19, following exposure...
An international research collaboration, involving scientists from the UK, US and Spain, has shed new light on the usefulness of digital contact tracing (DCT) to control the spread of Covid-19. The study, published today in Nature Communications, assessed the effectiveness of the Spanish DCT app, Radar COVID, following a 4-week experiment conducted in the Canary Islands, Spain between June-July 2020. For the...
Patients of Asian and black backgrounds suffered disproportionate rates of premature death from Covid-19, according to a study of 1,737 patients by Barts Health NHS Trust and Queen Mary University of London. The study, published in BMJ Open, is one of the most comprehensive studies exploring COVID-19 outcomes in black, Asian and minority ethnic populations so far reported, from one of the largest...
A new study, led by Barts Health NHS Trust and Queen Mary University of London seeks to understand why Black, Asian and minority ethnic communities are disproportionately affected by the Covid-19 virus. People from racial minorities are more likely to become very unwell or die from Covid-19 than those of white ethnicity. Compared to the general population, those of Black African heritage are 3.24 times more likely to die from Covid-19 and Bangladeshi populations are 2.41 times more likely...
Accessibility options
Translate the page